Evidence map›Paper›PMID 40893834›Full record

ArticleGenetics in medicine open2025

Pathogenic variation underlying rare diseases in an Arab population: Implications for screening programs.

Ruchi Jain, Sami Bizzari, Sathishkumar Ramaswamy, Khaleem F Hasham, Shruti Sinha, Ikram Chekroun, Fatma Rabea, Eman Abuijlan, Maha El Naofal, Massomeh Sheikh Hassani and 11 more

Abstract read
In one paragraph

Article in Genetics in medicine open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Ruchi JainDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Sami BizzariCentre for Arab Genomic Studies, Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences, Dubai, United Arab Emirates.
Sathishkumar RamaswamyDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Khaleem F HashamDubai American Academy, Dubai, United Arab Emirates.
Shruti SinhaDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Ikram ChekrounCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Fatma RabeaCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Eman AbuijlanCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Maha El NaofalDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Massomeh Sheikh HassaniDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Shruti ShenbagamDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Alan TaylorDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.
Mohammed UddinCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Mohamed AlmarriCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Omer AlkhnbashiCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Hamda KhansahebCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Hanan Al SuwaidiCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Stefan S Du PlessisCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Stephany El-HayekCentre for Arab Genomic Studies, Hamdan Bin Rashid Al Maktoum Foundation for Medical and Educational Sciences, Dubai, United Arab Emirates.
Alawi Alsheikh-AliCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates.
Ahmad Abou TayounDubai Health Genomic Medicine Center, Dubai Health, Dubai, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Genetic variation underlying rare diseases in Arab populations is poorly understood limiting effective carrier screening for recessive disorders, which are prevalent because of high consanguineous rates. Methods: Using the American College of Medical Genetics and Genomics/Association for Molecular Pathology guidelines, we curated pathogenic (P) and likely pathogenic (LP) variants in 1333 Arab Emirati families (346 internal cohort and 987 from the literature). We also analyzed P/LP variants in 1194 Emirati exomes, calculated allele frequencies, and estimated carrier rates for the associated recessive conditions. Results: Among the 1333 families, 1060 had 701 variants meeting the American College of Medical Genetics and Genomics/Association for Molecular Pathology criteria for pathogenicity, with 52% and 30% being absent from the Genome Aggregation Database and ClinVar databases, respectively. Independently, we determined the frequency of P/LP variants in 1194 Emirati exomes, as well as cumulative gene-disease carrier rates. The Conclusion: Our findings emphasize the necessity of identifying prevalent diseases in underrepresented populations to develop effective and equitable preventive public health measures, including premarital screening programs.

Indexed as

ConsanguinityExome sequencingGenetic variationMiddle EastRare genetic disorders

Identifiers

PMID40893834
PMCPMC12397869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.